POLARCOOL AB
PolarCool AB (publ), a medical device company, develops, markets, and sells products for sports medicine. The company offers PolarCap System, a portable cooling device for the treatment of concussive and sub-concussive brain injury. It serves teams, organizations, and athletes. PolarCool AB (publ) was incorporated in 2017 and is based in Lund, Sweden.
Market Cap & Net Worth: POLARCOOL AB (98H)
POLARCOOL AB (F:98H) has a market capitalization of $874.01 Million (€851.47 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #32541 globally and #3641 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying POLARCOOL AB's stock price €0.68 by its total outstanding shares 1255859968 (1.26 Billion).
POLARCOOL AB Market Cap History: 2021 to 2024
POLARCOOL AB's market capitalization history from 2021 to 2024. Data shows growth from $605.88 Million to $874.01 Million (15.68% CAGR).
POLARCOOL AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how POLARCOOL AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 98H by Market Capitalization
Companies near POLARCOOL AB in the global market cap rankings as of March 18, 2026.
Key companies related to POLARCOOL AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
POLARCOOL AB Historical Marketcap From 2021 to 2024
Between 2021 and today, POLARCOOL AB's market cap moved from $605.88 Million to $ 874.01 Million, with a yearly change of 15.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €874.01 Million | +5847.37% |
| 2023 | €14.70 Million | -86.71% |
| 2022 | €110.61 Million | -81.74% |
| 2021 | €605.88 Million | -- |
End of Day Market Cap According to Different Sources
On Dec 10th, 2025 the market cap of POLARCOOL AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $874.01 Million USD |
| MoneyControl | $874.01 Million USD |
| MarketWatch | $874.01 Million USD |
| marketcap.company | $874.01 Million USD |
| Reuters | $874.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.